The percentage of controlling LDL-C and non HDL-C reached the treament targets of risk categories: lower risk LDL-C 97.7%, non HDL 94.2%, moderate risk LDL-C 88.7%, non HDL-C 83.0%, moderately high risk LDL-C 56.0%, non HDL-C 54.0%, high risk LDL-C 23.1%, non HDL-C 23.1%.